Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Jason Zemansky is an analyst at B of A Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/28/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 06/28/2024 | INSM | Buy Now | Insmed | $67.00 | 23.88% | $62 → $83 | Maintains | Buy | Get Alert |
| 06/20/2024 | ESPR | Buy Now | Esperion Therapeutics | $2.23 | 12.11% | $2.9 → $2.5 | Downgrade | Neutral → Underperform | Get Alert |
| 05/29/2024 | INSM | Buy Now | Insmed | $67.00 | -7.46% | $40 → $62 | Maintains | Buy | Get Alert |
| 05/28/2024 | INSM | Buy Now | Insmed | $67.00 | -40.3% | $40 → $40 | Maintains | Buy | Get Alert |
| 05/23/2024 | CYTK | Buy Now | Cytokinetics | $54.18 | 10.74% | $70 → $60 | Maintains | Neutral | Get Alert |
| 12/26/2023 | ALVR | Buy Now | AlloVir | $0.73 | 36.17% | $17 → $1 | Downgrade | Buy → Underperform | Get Alert |
| 10/25/2023 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.53 | 41.26% | → $29 | Initiates | → Buy | Get Alert |
| 09/06/2023 | INSM | Buy Now | Insmed | $67.00 | -44.78% | $35 → $37 | Maintains | Buy | Get Alert |
| 09/05/2023 | RCUS | Buy Now | Arcus Biosciences | $15.23 | 51.02% | $21 → $23 | Maintains | Neutral | Get Alert |
| 08/18/2023 | ALVR | Buy Now | AlloVir | $0.73 | 2214.81% | → $17 | Initiates | → Buy | Get Alert |
| 08/11/2023 | KURA | Buy Now | Kura Oncology | $20.59 | 50.56% | → $31 | Initiates | → Buy | Get Alert |
| 07/03/2023 | RPHM | Buy Now | Reneo Pharmaceuticals | $1.53 | 1403.27% | → $23 | Initiates | → Buy | Get Alert |
| 06/15/2023 | ESPR | Buy Now | Esperion Therapeutics | $2.23 | 79.37% | $1.25 → $4 | Upgrade | Underperform → Buy | Get Alert |
| 05/12/2023 | HOWL | Buy Now | Werewolf Therapeutics | $2.44 | 309.84% | $9 → $10 | Maintains | Buy | Get Alert |
| 03/23/2023 | HOWL | Buy Now | Werewolf Therapeutics | $2.44 | 268.85% | → $9 | Reiterates | Buy → Buy | Get Alert |
| 03/16/2023 | ESPR | Buy Now | Esperion Therapeutics | $2.23 | -32.74% | $8 → $1.5 | Downgrade | Neutral → Underperform | Get Alert |
| 02/27/2023 | ESPR | Buy Now | Esperion Therapeutics | $2.23 | 258.74% | → $8 | Reinstates | → Neutral | Get Alert |
| 02/17/2023 | CYTK | Buy Now | Cytokinetics | $54.18 | -9.56% | → $49 | Initiates | → Neutral | Get Alert |
| 01/30/2023 | HOWL | Buy Now | Werewolf Therapeutics | $2.44 | 227.87% | $9 → $8 | Maintains | Buy | Get Alert |
| 11/18/2022 | RCUS | Buy Now | Arcus Biosciences | $15.23 | 116.68% | → $33 | Initiates | → Neutral | Get Alert |
| 11/18/2022 | INSM | Buy Now | Insmed | $67.00 | -41.79% | → $39 | Initiates | → Buy | Get Alert |
| 02/22/2022 | FIXX | Buy Now | Homology Medicines | — | — | $450 → $162 | Maintains | Buy | Get Alert |
| 12/13/2021 | ALLK | Buy Now | Allakos | $0.99 | 15556.57% | — | Maintains | Buy | Get Alert |
